Virtu Financial’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Buy |
+100,879
| New | +$113K | 0.01% | 1026 |
|
|
2023
Q1 | – | Sell |
-14,594
| Closed | -$147K | – | 1677 |
|
|
2022
Q4 | $147K | Buy |
14,594
+1,921
| +15% | +$19.4K | 0.02% | 825 |
|
|
2022
Q3 | $284K | Buy |
+12,673
| New | +$284K | 0.03% | 679 |
|
|
2021
Q2 | – | Sell |
-11,759
| Closed | -$970K | – | 1678 |
|
|
2021
Q1 | $970K | Buy |
+11,759
| New | +$970K | 0.07% | 264 |
|
|
2018
Q2 | – | Sell |
-16,521
| Closed | -$161K | – | 2112 |
|
|
2018
Q1 | $161K | Sell |
16,521
-1,730
| -9% | -$16.9K | 0.01% | 1442 |
|
|
2017
Q4 | $112K | Sell |
18,251
-242
| -1% | -$1.49K | 0.01% | 1875 |
|
|
2017
Q3 | $73K | Buy |
+18,493
| New | +$73K | ﹤0.01% | 2151 |
|